X
X

Dr. Vishal Rao

   MBBS, MS

Book An Appointment

Home / Doctors / Dr. Vishal Rao

Dr. Vishal Rao

  Qualification

MBBS, MS

  Specialities

Surgical Oncology
Robotic Surgery

  Locations

HCG Cancer Centre - K. R. Road, Bengaluru

  Experience

15 Years

Introduction
Expertise
  • Dr. Vishal is the Group Director for Head & Neck Surgical Oncology and Robotic Surgery at HCG Cancer Centre, Bengaluru.
  • He is also the dean for the Centre for Academic Research, HCG Academics.
  • He is well-experienced in the treatment of both benign and malignant tumours in the regions of the oral cavity (mouth), thyroid, neck, voice box, parotid and salivary glands.
  • Dr. Vishal is also an expert in performing complex neck surgeries like radical and modified neck dissections, carotid body tumours, other vascular tumours, and parapharyngeal space tumours. 
  • He also has a keen interest in cancer prevention and tobacco control programmes.
  • Dr. Vishal has handled more than 10000 cases so far.
Training and Certifications
  • Dr. Vishal is a Fellow of the Royal College of Surgeons FRCS (Glasgow), Fellow of the American College of surgeons FACS (USA), Member of the Royal Society of Medicine, fellowship in Head & Neck Oncosurgery from Tata Memorial Hospital, Mumbai.
  • He is certified and trained in Minimally Invasive Head Neck Surgical Oncology with Robotic Surgery and Laser Surgery
Recognition
  • Dr. Vishal is the inventor of Aum Voice Prosthesis - a $1 speaking device designed for throat cancer patients.
  • Dr. Vishal is recognised by BBC, Harvard Business Review & Forbes for his work on treatment techniques, drugs, medical devices and theories. He has over 18 patents named under him for his innovation in multiple areas.
  • His contribution to the oncology field has been recognised with the Honorary FRCS from the Royal College of Surgeons in Glasgow.
  • He is also honoured with the Judy Wilkenfield award for Global Excellence in Tobacco Control. 
  • Dr. Vishal is an international advisor to WHO's Tobacco Free Initiative partners.
  • The other positions held by Dr Rao are, Member of the Union for International Cancer Control (UICC) Globalink - Global Tobacco Control; a Member of National Executive Committee for the Foundation of Head and Neck Oncology (FHNO); Executive Board Member of the State Association for Otolaryngology-Head and Neck Surgery, Karnataka and a Member of the Action Council against Tobacco (ACT) - India.
  • Dr. Vishal is a visiting faculty of John Hopkins University leadership programs.
  • He also serves as editor of the journal of precision oncology and has over 100 national & international publications to his credit.
  • He has been a recipient of several awards: Kempegowda Award - highest civil award conferred by the Bengaluru Corporation, the Varshada Kannadiga Award 2018 (Kannadiga of the Year) for his contributions to Science and Technology.
  • He is also the recipient of the Rotary Vocational Training Award 2016 for inventing the voice prosthesis for his throat cancer patients.
Publications
  • Role of Adjuvant Radiotherapy in Early Stage Tongue Cancer: Need for Establishing Stringent Guidelines. Rao V, Subash A, Sinha P, Shetty S, Thakur S, Merchant Y, Kudpaje A, Arakeri G. Indian J Surg Oncol. 2021 Sep;12(3):549-553. 
  • COVID-19 associated mucormycosis (CAM) in India: a formidable challenge. Rao VUS, Arakeri G, Madikeri G, Shah A, Oeppen RS, Brennan PA. Br J Oral Maxillofac Surg. 2021 Jun 29:S0266-4356(21)00245-X. 
  • Transoral retroauricular neck dissection (TREND): A novel combination approach. Kudpaje A, BhanuPrakash B, Thakur S, Arakeri G, Rao VUS. Int J Oral Maxillofac Surg. 2021 Aug 7:S0901-5027(21)00245-9. 
  • Decreased Cancer Consultations in the COVID-19 Era: A Concern for Delay in Early Cancer Diagnosis in India. Rao V, Arakeri G, Subash A, Ajaikumar BS, Patil R, Hale B, Amaral Mendes R. JCO Glob Oncol. 2021 Mar;7:408-409. 
  • Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomas. Rao VUS, Subash A, R Bhargavi V, Sinha P, Bagadia RK, Kudpaje A, Arakeri G, Subbanna I. Head Neck. 2021 Apr;43(4):1174-1183. 
  • Are carcinogens electron acceptors? A novel hypothesis. Vishal Rao US, Arakeri G, Subash A, Venkatesh M, Brennan PA. Med Hypotheses. 2020 Nov;144:110235. 
  • Circulating tumour cells in head and neck cancers: Biological insights. Rao V US, Arakeri G, Subash A, Bagadia RK, Thakur S, Kudpaje AS, Nayar R, Patil S, Paiva Fonseca F, Gomez RS, Brennan PA. J Oral Pathol Med. 2020 Oct;49(9):842-848. 
  • COVID-19: Loss of bridging between innate and adaptive immunity? Rao VUS, Arakeri G, Subash A, Rao J, Jadhav S, Suhail Sayeed M, Rao G, Brennan PA. Med Hypotheses. 2020 Nov;144:109861. 
  • The E-cigarette ban in India-A step in the right direction? Vishal Rao US, Arakeri G, Ravishankar S, Kar A, Thakur S, Li RJ, Dhananjay KV, Surya T, Chaturvedi P, Gomez RS, Brennan PA. J Oral Pathol Med. 2020 Aug;49(7):617-620. 
  • Carotid body tumours: objective criteria to predict the Shamblin group on MR imaging. Arya S, Rao V, Juvekar S, Dcruz AK. AJNR Am J Neuroradiol. 2008 Aug;29(7):1349-54.

   Practices at

Other Doctors

HCG Call Icon